Antibiotics Flashcards

1
Q

Time dependent

A

activity correlates with the amount of time spent above the MIC
long time at low concentration
ex. B-lactam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Concentration dependent

A

activity correlates with peak concentration/MIC ratio; depend on concentration in the blood
short time at high concentration
ex. aminoglycosides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Acquired resistance

A
  1. inactivation of abx by enzyme
  2. decreased uptake of abx
  3. Efflux of abx
  4. Altered target site decreased abx affinity
  5. Bypass target process
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Vertical transfer

A

spontaneous mutation

abx = selective pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Horizontal transfer

A

conjugation
transfer of plasmid DNA from one cell to another by direct contact
primarily gram (-), leads to MDR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

High-level resistance

A

cannot be overcome by increasing the abx dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Low-level resistance

A

can be overcome by increasing the dose and increase the efficacy
can become high level resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Superinfection

A

New (abx-induced) infx occurring during tx of a primary infx superimposed
Ex. CDIFF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Decreased kidney or liver function

A

1) Decrease dose/Decrease dose interval

2) Switch to abx cleared by liver or kidney

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Pregnancy issues

A

reduce efficacy of contraceptives - metabolized faster
maternal toxicity - class D drugs
Tetracycline (bone), aminoglycosides (ototoxicity of fetus), sufonamide (kernicterus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Combination therapy- why is it used? What’s bad about it?

A

Mixed bacterial infections
Unknown etiology/resistance suspected
Prevent emergence of resistant microbes (TB*)
Bad - increases the spectrum and increases risk of superinfection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Prophylactic tx what are some specific uses?

A
  1. before surgery
  2. bacterial endocarditis before dentist
  3. immunocompromised
  4. reccurent infections like UTI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Gram Positive Bacteria

A

Thick peptidoglycan wall

Hydrophilic and hydrophobic (lesser extent) can passively diffuse across

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Gram Negative Bacteria

A

Thin cell wall!
Outer lipid membrane hinders transport of many abx
Small hydrophilic drugs can cross through porins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

B lactam ring

A

High affinity for Penicillin Binding Protein (PBP) that are involved in polymerization and crosslinking of peptidoglycan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Innately resistant to B lactams

A

Chlamydia, Mycoplasma, Legionella - lack peptidoglycan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Beta lactam mechanism

A

Time dependent, Most effective during log growth phase
Bind to PBP = inhibition activates autolysins
Bactericidal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Penicillin

A
B-lactam + 5 membered ring
PBP affinity
gram-negative outer envelope penetration
stability in gastric acid - oral 
R group can be altered
Most are well absorbed
Short half life, must give frequently
Excreted unchanged = highly concentrated in urine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Penicillin adverse reactions

A
Least toxic
*Jarisch-Herxheimer rxn**
CNS toxicity
Pen G cannot be given by IV
Penicillin allergy - not due to allergy; due to non-enzymatic breakdown to penicilloyl that form haptens = maculopapular rash
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Pen G and Pen V

A

Standard Penicillins
Active against gram+ and some gram-
Pen G unstable in stomach (need IM) - syphilis, rheumatic fever
Pen V acid stable, orally effective - strep

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Naficillin

A
Anti-staphylococcal
R group altered to protect against B lactamase
Active against Pen G resistant, MSSA
*No gram- or anaerobic activity*
MRSA emergence due to altered PBP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Amoxicillin

A

Aminopenicillin
+ charged R-group, can enter through gram- porins
in combo with B lacatamase inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Ticarcillin, piperacillin

A

Anti-pseudomonal
Susceptibility - aminopenicillin+P. aeruginosa
used w/ B lactamase inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Clavulanic acid

A

B-lactamase inhibitor
Amoxicillin/clavulanate (augmentin)
Ticarcillin/clavulanate (timentin)
piperacillin/tazobactam (zosyn)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Cephalosporin

A
B lactam ring + 6 membered ring
Resistance due to B lactamase and altered PBP
5 generations
Most given parenterally, poor absorption
Cleared by kidney
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Cefazolin

A

1st generation
surgical site prophylaxis (MSSA, S aureus)
alternative for MSSA when penicillin allergy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Cefoxitin

A

2nd generation
Gram(-) bacteria - higher affinity of PBPs, greater cell wall penetration, better resistance to B lactamase
Not as good for gram(+) as 1st gen
*Cephamycin works against GI anaerobes

28
Q

Ceftriaxone

A
3rd generation
Higher activity against gram(-)
Good CNS penetration
Most widely used 
Tx: gram(-) meningitis (N. meningitis, H influenzae), and gonorrhea, less active against strep
29
Q

Cefepime

A

4th generation
Highly resistant B lactamases and broad antibacterial spectrum
Good CNS penetration
Useful for empiric tx, drug resistance

30
Q

Ceftaroline

A

5th generation

ONLY cephalosporin active against MRSA

31
Q

Carbapenems, imipenem-cilastatin (primaxin)

A

B lactams w/ broad spectrum
Structure similar to penicillin
Active against: gram(+) and gram(-), Pseudomonas and anaerobes
Resistant to inactivation by B-lactamases
Given parenterally, eliminated by kidney
Clistatin prevents renal inactivation
Tx: Used for MDR ESBL, anaerobic and mixed infections

32
Q

Aztreonam

A

Monobactam
B lactam not fused to second ring
NARROW SPECTRUM - gram(-) anaerobes including Pseudomonas
resistant to most B lactamases
IV systemic
Inhalation - CF and P aeruginosa
good for penicillin allergy* for gram(-) PNEU, meningitis or sepsis

33
Q

Vancomycin

A

serious resistant infxs
prevents polymerization of cell wall precursor NAM-NAG = bactericidal
Cannot penetrate gram(-) size
= ONLY Gram(+)
D-Ala-D-lactate, decreased binding affinity = resistance
Systemic IV, CDIFF oral

34
Q

Bacteria resistant to vancomycin are treated with:

A

Treated w/ Linezolid, Daptomycin, quinupristin/dalfopristin

35
Q

Adverse reactions of vancomycin

A

Ototoxic >30ug/mL
Nephrotoxic
***Rapid infusion “red man” syndrome - flushing urticaria, tachycardia, hypotension, histamine release

36
Q

Fosfomycin (nitrofurantoin)

A

Bactericidal, inhibits production of murein in CYTOSOL by inhibiting synthese of UDP-NAM from UDP-NAG
Enters via glycerophosphate transporter
Mutations in transporter = resistance
Tx: uncomplicated UTIs in women (E coli)

37
Q

Gentamicin and Amikacin

A

Highly polar, cation, not capable of passive diffusion
Bactericidal
Concentration dependent
Active against TB
Require O2 transporter to enter cell
Bind to 30S subunit
Combination tx for serious gram(-) infx (vanco)

38
Q

Adverse effects of Gentamicin

A

Ototoxicity
Nephrotoxicity (reversible damage to proximal tubules)
Neuromuscular blocakde at high doses -> respiratory paralysis
Contraindicated in myasthenia gravis

39
Q

Doxycycline

A

Active transported into bacterial cells
30s ribosome subunit inhibits binding of tRNA at A-site and prevent addition of amino acids
Oral effective
*DO NOT CONSUME w/ chelates (Ca2+, Mg2+ etc)

40
Q

Tigecycline

A

addition of side chain=resistant to efflux and increased binding affinity
restore efficacy
Tx: Highly resistant gram(-) infections
VERY TOXIC - other drugs preferred

41
Q

Azithromycin, Clarithromycin

A

Bind reversibly to 50S subunit, inhibit translocation
Overlap clindamycin/chloramphenicol binding sites = antagonism
Tx: Respiratory tract infections, atypical organisms, Peptic ulcer disease
CYP3A4 inhibitor = drug interactions

42
Q

Clindamycin

A
Lincosamides
50S subunit, block peptide formation
bacteriostatic
Gram(+), anaerobs
Tx: SSIs, intraabdominal MRSA and Strep, severe acne, bacterial vaginosis, gas gangrene
Adverse: CDAD
43
Q

Chloramphenicol

A

50S subunit prevent tRNA attachment
Broad spectrum
Rarely used in U.S. except for meningitis
Adverse: Gray baby syndrome, blood dyscrasias (bone marrow suppression, aplastic anemia)

44
Q

Linezolid

A
23S rRNA of 50S subunit
blocks formation of initation complex
Gram(+)
Tx: SSIs, MDR (MRSA, VRE) 
Interact w/ SSRIs and MAOs = serotonin syndrome
45
Q

Quiniupristin-dalfopristin

A

23S rRNA 50S
Same site as macrolide
Tx: SSIs (MRSA), VRE
Adverse: Hyperbilirubinemia, arthralgia, myalgia, phlebitis (necrosis at injection site)

46
Q

Ciprofloxacin

A

Fluoroquinolone
Bactericidal, Broad
DNA gyrase/topoisomerase IV
Tx: UTIs, ANTHRAX, diarrhea, Pseudomonas, H flu, respiratory infx
Adverse: Tendon rupture*, contraindicated in mysathenia gravis

47
Q

Metronidazole

A

Bactericidal
Prodrug -> p4 oxidoreductase
“SHOT GUN” Effect = no resistance
Tx: CDAD drug of choice, intra-abdominal anaerobic infx
Adverse: supposedly carcinogenic, ethanol

48
Q

Folic acid

A

synthesis of nucleic acids, AA, tRNA, metabolites
targeted by drugs
Mammals from diet, bacteria must create by PABA, pteridine, glutamate

49
Q

Sulfamethoxazole (SMX)

A

PABA structural analog, competitive inhibitor of Dihydropterorate synthase enzyme
*Adverse: kernicterus, SJS, Hemolytic anemia
Used w/ Trimethoprim usually

50
Q

Trimethoprim

A

Competitive inhibitor of dihyrofolate reductase (DHFR); >40,000 binding affinity for bacteria
Combine w/ sulfa
Tx: uncomplicated UTI and otitis media
Adverse: bone marrow suprression, hyperkalemia

51
Q

Co-trimoxazole (Bactrim)

A
TMP/SMX
Bactericidal synergistic combo
#1 drug for UTIs
Tx: SSIs (MRSA), prophylaxis PCP PNEU
Adverse: HIV problems
52
Q

Fidaxomicin (rifampin)

A

Macrolide structure BUT
RNA polymerase inhibitor
Tx: CDIFF better than vanco and metronidazole because does not kill normal flora

53
Q

Daptomycin (cubicin)

A

“Bee stinger” Ca2+ dependent insertion of lipophilic tail into plasma membrane forms channel that permits influx of K+ = membrane depolarization
Bactericidal
ONLY Gram(+), inactivated by surfactant
IV administer
Tx: SSIs (resistant), staph endocarditis EOSINOPHILIC PNEU

54
Q

Colistin (polymixin)

A

Hydrophobic tail has detergent effect and disrupts outer and plasma membrane to increase permeability
Colistin sulfate - topical and oral
Colistimethate - anionic parenteral, prodrug
ESKAPE - MDR infxs
Adverse: nephrotoxicity

55
Q

Mycoplasma TB innate resistance

A

Highly complex cell wall (mycolic acid)
Efflux transporters
Intracellular location of infection
Slow proliferation

56
Q

Acquired resistance of TB

A

Spontaneous mutation - longterm therapy

57
Q

MDR TB

A

INH + rifampin resistance

58
Q

Extensively drug resistant TB (XTR)

A

MDR + resistance to fluoroquinolones and aminoglycosides

59
Q

Isoniazid (INH)

A

Inhibits synthesis of mycolic acid - free radical bind to NAD/NADPH
Active against both intracellular and extracellular
Toxic in slow acetylators
Adverse: HEPATOTOXICITY

60
Q

Rifampin (for TB)

A

Bind to B subunit of bacterial RNA polymerase, inhibiting RNA synthesis
Bactericidal
High resistance - mutation in rpoB gene
In combo with INH for TB, can tx MAC
Adverse: Hepatotoxicity, CYP450 induction (contraceptives, warfarin, HIV drugs),

61
Q

Ethambutol

A

Disrupt assembly of mycobacterial cell wall
Inhibit mycobacterial arabinosyl transferase
Resistance due to embAB gene (enzyme)
TX: in combo for TB, MAC
Adverse: *Optic neuritis, *NO liver effects

62
Q

Pyrazinamide

A
Prodrug converted to pryazinoic acid (POA) by mycobacterial pyrazinamidase
Bactericidal
Unknown target
Tx: in combo for TB
Adverse: hepatotoxcityl
63
Q

Streptomycin

A

Second line antimycobacterial agent
Aminoglycoside for MDR TB
Severe life threatening forms of TB
Active against extracellular bacilli but not intracellular

64
Q

Prophylaxis TB Treatment

A

Monotherapy for latent prevent active
INH x9 months
Rifampin x4 months

65
Q

Active TB Treatment

A

IREP combination
Induction phase (2 months) - IREP; eliminate actively dividing extracellular organisms and make non-infectious
Continuation phase (4 months) - INH+rifampin usually after susceptibility testing
Monitor for hepatotoxicity

66
Q

Beta lactams

A

Penicillins
Cephalosporins
Carbapenems
Monobactams

67
Q

ESKAPE

A
Enterococcus faecium
Staphylococcus aureus
Klebsiella pneumoniae
Acinetobacter baumannii
Pseudomonas aeruginosa
Enterobacter specie

Colistimethate targets